Vetmab Biosciences, Inc. reports $11.4M Series A round
Vetmab Biosciences, Inc. reported an estimated $11.4M Series A round in its first SEC Form D filing. The company filed on September 29, 2026, for a first sale date of September 17, 2026. Rounds are estimates.
This is the only funding round Vetmab Biosciences, Inc. has reported in its SEC filings to date.
Denise Bevers, Richard Chin, Hangjun Zhan, Neeraj Agrawal, and Chrysa Mineo are named in the latest filing. Vetmab Biosciences, Inc. is not yet tracked for open roles.
Every Form D filing
| First sale | Amount sold | Est. round |
|---|---|---|
| 2026-09-17 | $11.4M | Series A |
Named in the latest filing
- Denise Bevers
- Richard Chin
- Hangjun Zhan
- Neeraj Agrawal
- Chrysa Mineo
From SEC Form D filings. Rounds are our estimate from the amount sold; filings carry no valuation. All filings on SEC EDGAR